VANCE: First-in-human phase I study of a novel ChAdOx1-MVA 5T4 vaccine in low and intermediate risk prostate cancer

Míreanna comhchosúla

• Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control
  de réir: Wajja, A, et al.
  Foilsithe / Cruthaithe: (2024)
• Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
  de réir: Zhang, C, et al.
  Foilsithe / Cruthaithe: (2023)
• Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBV
  de réir: Charlotte Davis, et al.
  Foilsithe / Cruthaithe: (2024-06-01)
• Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
  de réir: Cheng Zhang, et al.
  Foilsithe / Cruthaithe: (2023-06-01)
• Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
  de réir: Adam Berg, et al.
  Foilsithe / Cruthaithe: (2021-10-01)